Determinants of poor adherence in hypertensive patients: Development and validation of the "Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire"

Patient Education and Counseling

Volumn 64, Issue 1-3, 2006, Pages 151-158

  Wetzels, Gwenn ^a   Nelemans, Patty ^a   van Wijk, Boris ^b   Broers, Nick ^a   Schouten, Jan ^c   Prins, Martin ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adherence; Convergent validity; Factor analysis; Hypertension; Patient compliance; Questionnaire

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EVALUATION; FACTORIAL ANALYSIS; FEMALE; HEALTH CARE DELIVERY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; REGRESSION ANALYSIS; STANDARDIZATION; STATISTICAL ANALYSIS;

ADAPTATION, PSYCHOLOGICAL; AGED; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; DRUG MONITORING; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NETHERLANDS; NURSING ASSESSMENT; NURSING EVALUATION RESEARCH; PATIENT COMPLIANCE; PSYCHOMETRICS; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SELF ADMINISTRATION; SENSITIVITY AND SPECIFICITY;

EID: 33751097486     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2005.12.010     Document Type: Article

References (37)

1. Burt V.L., Cutler J.A., Higgins M., Horan M.J., Labarthe D., Whelton P., et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 26 (1995) 60-69
2. Joint National Committee on prevention d, evaluation, and treatment of high blood pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157:2413-46.
3. Sabate E. Adherence to long-term therapies: evidence for action (2003), WHO, Geneva
4. O'Rorke J.E., and Richardson W.S. Evidence based management of hypertension: what to do when blood pressure is difficult to control. Brit Med J 322 (2001) 1229-1232
5. Urquhart J. Partial compliance in cardiovascular disease: risk implications. Brit J Clin Pract Suppl 73 (1994) 2-12
6. Mar J., and Rodriguez-Artalejo F. Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance?. J Hypertens 19 (2001) 149-155
7. Nuesch R., Schroeder K., Dieterle T., Martina B., and Battegay E. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. Brit Med J 323 (2001) 142-146
8. Wright E.C. Non-compliance-or how many aunts has Matilda?. Lancet 342 (1993) 909-913
9. Benson J., and Britten N. Patients' decisions about whether or not to take antihypertensive drugs: qualitative study. Brit Med J 325 (2002) 873
10. Oliveria S.A., Lapuerta P., McCarthy B.D., L'Italien G.J., Berlowitz D.R., and Asch S.M. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 162 (2002) 413-420
11. Urquhart J. Role of patient compliance in clinical pharmacokinetics. A review of recent research. Clin Pharmacokinet 27 (1994) 202-215
12. Urquhart J. Patient compliance with prescribed drug regimens: overview of the past 30 years of research. Clin Meas Drug Eval (1995) 213-227
13. Cramer J.A. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 49 (1995) 321-327
14. Urquhart J. The electronic medication event monitor. Lessons for pharmacotherapy. Clin Pharmacokinet 32 (1997) 345-356
15. Bertholet N., Favrat B., Fallab-Stubi C.L., Brunner H.R., and Burnier M. Why objective monitoring of compliance is important in the management of hypertension. J Clin Hypertens (Greenwich) 2 (2000) 258-262
16. Burnier M., Schneider M.P., Chiolero A., Stubi C.L., and Brunner H.R. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 19 (2001) 335-341
17. Mallion J.M., Dutrey-Dupagne C., Vaur L., Genes N., Renault M., Elkik F., et al. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens 14 (1996) 137-144
18. Haynes R.B., McKibbon K.A., and Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 348 (1996) 383-386
19. Davidson M.H. Strategies to improve Adult Treatment Panel III guideline adherence and patient compliance. Am J Cardiol 89 (2002) 8C-20C [discussion 20C-22C]
20. Bond W.S., and Hussar D.A. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 48 (1991) 1978-1988
21. McDonald H.P., Garg A.X., and Haynes R.B. Interventions to enhance patient adherence to medication prescriptions: scientific review. J Am Med 288 (2002) 2868-2879
22. Craig H.M. Accuracy of indirect measures of medication compliance in hypertension. Res Nurs Health 8 (1985) 61-66
23. Inui T.S., Carter W.B., and Pecoraro R.E. Screening for non-compliance among patients with hypertension: is self-report the best available measure?. Med Care 19 (1981) 1061-1064
24. Haynes R.B., Taylor D.W., and Sackett D.L. Can simple clinical measurements detect patient compliance?. Hypertension 2 (1980) 757-764
25. Svarstad B., Chewning B.A., Sleath B.L., and Claesson C. The brief medication questionnaire: a tool for screening adherence and barriers to adherence. Patient Educ Couns 37 (1999) 113-124
26. Morisky D.E., Green L.W., and Levine D.M. Concurrent and predictive ability of a self-reported measure of medication adherence. Med Care 24 (1986) 67-73
27. Geijer RMM, Burgers J.S., Van der Laan J.R., Wiersma T., Rosmalen CFH, and Thomas S. NHG-Standaard Hypertensie, tweede herziening. NHG-standaarden voor de huisarts, deel 1 (1999), Elsevier/Bunge, Maarssen p. 187-205
28. Urquhart J. Some economic consequences of noncompliance. Curr Hypertens Rep 3 (2001) 473-480
29. Claxton A.J., Cramer J., and Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23 (2001) 1296-1310
30. Feely J. The therapeutic gap-compliance with medication and guidelines. Atherosclerosis 147 (1999) S31-S37
31. Haynes R.B., Taylor D.W., and Sackett D.L. Compliance in health care (1997), John Hopkins University Press
32. Steiner J.F., and Prochazka A.V. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 50 (1997) 105-116
33. Waeber B., Vetter W., Darioli R., Keller U., and Brunner H.R. Improved blood pressure control by monitoring compliance with antihypertensive therapy. Int J Clin Pract 53 (1999) 37-38
34. Waeber B., Leonetti G., Kolloch R., and McInnes G.T. Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study. J Hypertens 17 (1999) 1041-1045
35. Choo P.W., Rand C.S., Inui T.S., Lee M.T., Canning C., and Platt R. Derivation of adherence metrics from electronic dosing records. J Clin Epidemiol 54 (2001) 619-626
36. Cook C.L., Wade W.E., Martin B.C., and Perri M. Concordance among three self-reported measures of medication adherence and pharmacy refill records. J Am Pharm Assoc (2005) 45
37. Bovet P., Burnier M., Madeleine G., Waeber B., and Paccaud F. Monitoring one-year compliance to antihypertension medication in the Seychelles. B World Health Organ 80 (2002) 33-39